News

Axcelis Technologies (NASDAQ:ACLS) reported first-quarter 2026 results that came in “slightly above our expectations,” according to President and CEO Russell Low, as the company pointed to strength in its customer support and installed base business and a meaningful uptick in memory demand. The com

Axcelis (ACLS) delivered earnings and revenue surprises of +1.41% and +2.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

(Bloomberg) -- CoreWeave Inc. shares are on a scorching run in 2026 as demand for computing capacity to power artificial intelligence keeps growing. But now investors want to see some proof that the neo-cloud provider is executing on its ambitious plans. Most Read from BloombergBillionaire Duke of Westminster to Sell £700 Million of US Real Estate AssetsUS Has Opened a Passage Through Hormuz, Central Command SaysDOJ Plans Intervention in Trump Supreme Court Carroll AppealChina Asks Banks to Paus

Kulicke and Soffa (KLIC) delivered earnings and revenue surprises of +17.91% and +5.49%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

The latest trading day saw Axcelis Technologies (ACLS) settling at $143.13, representing a +2.34% change from its previous close.

Axcelis Technologies is back in focus as analysts reset price targets into the low US$90s range, with a model fair value sitting at US$92.0. These updated targets reflect a tug of war between solid recent execution and more cautious expectations for calendar 2026 to 2028, where trimmed revenue and EPS estimates are tempering prior optimism. As you read on, you will see what is driving this evolving narrative and how to keep track of the key signals that matter. Stay updated as the Fair Value...

ACLS' $4.4B all-stock deal for VECO could broaden its tool lineup - if integration and China approval do not slow a near-term close.

OneSpaWorld Holdings provides wellness and beauty services on cruise ships and at resorts, supported by exclusive industry partnerships.

AdaptHealth delivers home medical equipment and chronic care solutions through a recurring-revenue model.

For years, owning small-cap stocks felt like watching a neighbor’s party through a window. Large-cap indexes kept climbing, mega-cap technology names absorbed Wall Street’s attention, and smaller domestic companies sat quietly in the corner, undervalued and overlooked. That dynamic may finally be shifting. SPY, the large-cap proxy, returned 64% over the past three years. IJR ... Small-Cap Stocks May Be About to Pull Ahead, and IJR Will Win Big

ACI Worldwide enables digital payment and fraud prevention solutions for banks, merchants, and organizations across regulated sectors.

Axcelis Technologies (ACLS) is back on traders’ radar after a sharp move in the share price, with the stock showing strong gains over the past month and over the past 3 months. See our latest analysis for Axcelis Technologies. The recent 30-day share price return of 32.67% and 7-day move of 16.07% suggest momentum is building, set against a 1-year total shareholder return of 134.58% and a more mixed 3-year record. If Axcelis has caught your attention, this could be a good moment to see what...